Barclays cuts CoreWeave stock rating, raises target to $100

Barclays downgraded CoreWeave (CRWV) to Equal Weight from Overweight, raising the price target to $100 from $70, citing valuation concerns despite strong growth prospects in the GenAI sector; the stock currently trades at a premium with a 41x EV/EBIT multiple for 2026 incorporating $31.4B in gross debt. Recent news includes a $2B senior notes offering for general corporate purposes and mixed ratings from Moody's (Ba3) and S&P Global ('B+'), while Citi raised its target to $94 after strong Q1 results offset by weaker margins, highlighting potential risks from customer concentration and rapid cash burn.

Analysis

Barclays' recent revision of CoreWeave (CRWV) to Equal Weight from Overweight, despite an increased price target to $100 from $70, signals a cautious stance primarily driven by valuation concerns. The company currently trades at a significant premium, reflected by a 41x enterprise value to earnings before interest and taxes (EV/EBIT) multiple for calendar year 2026, which incorporates an anticipated gross debt of approximately $31.4 billion, following a substantial stock appreciation exceeding 150% in the past six months. While Barclays acknowledges CoreWeave's strong growth trajectory and pivotal role in the Generation AI (GenAI) theme, the firm notes a lack of immediate catalysts to propel the stock higher and points to InvestingPro data indicating rapid cash burn and a concerning current ratio of 0.44, where short-term obligations exceed liquid assets. The new $100 price target itself is based on a higher 40x EV/EBIT multiple for 2026 (up from a previous 27x assumption), albeit applied to a reduced 2026 EBIT estimate of $2.21 billion (down from $2.52 billion) and higher projected net debt. CoreWeave recently upsized a senior notes offering to $2 billion, securing a Ba3 corporate family rating from Moody's and a 'B+' issuer credit rating from S&P Global, reflecting its financial strategy and risk profile. Other analysts offer varied perspectives: Citi raised its target to $94 following a 15 percentage point Q1 revenue beat, though margins and net income were weaker, while Citizens JMP initiated with a Market Perform, highlighting growth sustainability risks due to increasing bargaining power of large customers and existing supplier/customer concentration, despite a strong NVIDIA relationship and contracted revenue backlog.

Key Decisions for Investors

• Exercise caution with CoreWeave (CRWV) positions due to its recent significant stock appreciation, high valuation (41x CY26 EV/EBIT), and Barclays' downgrade to Equal Weight suggesting limited near-term upside despite a higher price target.
• Closely monitor CoreWeave's key financial metrics including its rapid cash burn, liquidity (current ratio 0.44), increasing debt levels (projected $31.4B by 2026), and margin pressures, as these represent significant operational risks.
• Balance the company's strong long-term GenAI growth prospects and strategic partnerships against material risks like customer/supplier concentration and the sustainability of its high growth amid increasing large-customer bargaining power.
• Incorporate the speculative-grade credit ratings (Moody's Ba3, S&P 'B+') into risk assessments, as they reflect underlying financial vulnerabilities associated with CoreWeave's aggressive, debt-fueled expansion strategy.